Visa stock slips as DOJ antitrust fight stays in focus; 3 dates investors are circling
7 January 2026
2 mins read

Visa stock slips as DOJ antitrust fight stays in focus; 3 dates investors are circling

New York, January 7, 2026, 14:46 EST — Regular session

  • Visa shares dipped about 0.3% in afternoon trading, lagging Mastercard’s gain.
  • U.S. antitrust litigation over Visa’s debit practices and a separate card-fee settlement fight are back on investors’ screens.
  • Traders are watching Friday’s U.S. jobs report and a mid-January court scheduling update.

Visa Inc shares slipped 0.3% to $356.59 in afternoon trading on Wednesday, as investors weighed fresh developments in U.S. litigation over the payments network’s debit practices and card fees.

The move came with Wall Street mixed after a strong start to the year, as investors digested labor data ahead of Friday’s U.S. nonfarm payrolls report. The Dow was down about 0.3%, while the S&P 500 was flat and the Nasdaq edged higher. 1

Data on Wednesday also pointed to a firmer end to 2025 for the services-heavy U.S. economy, a key input for card spending trends. The Institute for Supply Management’s nonmanufacturing PMI rose to 54.4 in December from 52.6, and its prices gauge stayed elevated, keeping the inflation debate alive. 2

In the debit antitrust case, the Justice Department has pressed to keep the litigation moving, arguing in a joint filing with Visa that delays should not drag out the evidence-gathering phase, known as discovery. DOJ lawyers said the government “has a sovereign interest in moving the matter forward expeditiously,” while Visa said the proposed schedule would make coordination with private plaintiffs “a practical impossibility,” according to Payments Dive. The parties told the court they would update it by Jan. 16 as they await a decision on the schedule.

Separately, consumer and business advocacy groups this week joined merchants in objecting to a proposed settlement over interchange fees — the fee merchants ultimately pay through the card system when customers use Visa and Mastercard-branded credit cards. The groups said the deal’s proposed fee reductions could be too easy to work around, Payments Dive reported, and noted it would also leave intact key industry practices such as centrally set interchange rates.

On the company side, a securities filing showed Visa CEO Ryan McInerney exercised 10,485 stock options on Jan. 2 and sold 10,485 shares at $349.18 each the same day, leaving him with 9,401 shares directly owned. The Form 4 said the trades were made under a Rule 10b5-1 plan — a pre-arranged trading program set up in advance. 3

Visa closed at $357.56 on Tuesday, up 1.06% on the day, but it remains about 4.8% below its 52-week high, MarketWatch data showed. Rival Mastercard shares were up about 0.8% on Wednesday, while American Express was down about 0.4%. 4

But the near-term setup is messy. Legal outcomes can shift timelines and costs, and any remedy that forces pricing or rule changes could hit the network’s fee engine; at the same time, the industry is grappling with fraud risk as commerce becomes more automated. “2026 will, unfortunately, see a material increase in the sophistication and volume of these AI powered identity attacks,” Visa Group President Oliver Jenkyn said in a company post cited by Payments Dive.

Next up, investors will watch Visa’s annual meeting on Jan. 27 and then turn quickly to quarterly results — Nasdaq currently estimates Visa will report earnings on Jan. 29. 5

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Goldman Sachs stock slips as bank rally cools, with earnings next week in focus
Previous Story

Goldman Sachs stock slips as bank rally cools, with earnings next week in focus

Bitmine (BMNR) stock slides as $14.2B crypto stash update meets dilution vote deadline
Next Story

Bitmine (BMNR) stock slides as $14.2B crypto stash update meets dilution vote deadline

Go toTop